Cocrystal Pharma
COCP
$1.56
Share price
2.30%
Change (1 day)
-36.53%
Change (1 year)
Categories
P/S ratio for Cocrystal Pharma (COCP)
P/S ratio as of April 2024 (TTM): N/A
According to Cocrystal Pharma 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2023 the company had a P/S ratio of N/A.
P/S ratio history for Cocrystal Pharma from 2009 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | N/A | |
| 2022 | N/A | |
| 2021 | N/A | -100% |
| 2020 | 46.3 | 1644.91% |
| 2019 | 2.65 | |
| 2018 | N/A | |
| 2017 | N/A | |
| 2016 | N/A | -100% |
| 2015 | > 1000 | 38.61% |
| 2014 | > 1000 | |
| 2013 | N/A | -100% |
| 2012 | 12.0 | -37.67% |
| 2011 | 19.3 | |
| 2009 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 3.79 | N/A | 🇺🇸 USA |
 Merck MRK | 5.53 | N/A | 🇺🇸 USA |
 Nature's Sunshine Products NATR | 0.8293 | N/A | 🇺🇸 USA |
 USANA USNA | 0.9083 | N/A | 🇺🇸 USA |